Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Cystine/glutamate antiporter roles in skeletal muscle glucose metabolism throughout differentiation

FY 2023-24

Summary
Skeletal muscles (SKM) have the remarkable ability to regenerate following injury; however, this healing process relies on a careful balance of reactive oxygen species. In fact, disturbances in this balance are often linked to diseases in muscles like muscular dystrophies. To maintain this delicate balance, muscle cells use antioxidants like glutathione (GSH), which is made up of amino acids, including cysteine. Cysteine is brought into cells through a transporter called xCT. Despite the documented importance of xCT, we don't fully understand its role in muscle health. In our previous work in mice with a mutant xCT gene, we found that differentiated xCT-mutant muscle cells had lower GSH levels compared to normal mice, and higher capacities to use glucose for ATP synthesis through glycolysis and mitochondrial oxidative phosphorylation. These previous findings suggest that changes in xCT activity lead to glucose-dependent metabolic alterations in SKM under oxidative stress. Hence, we hypothesize that modulation of xCT activity elicits differential changes in how muscle cells use glucose during different stages of proliferation and differentiation. To investigate this hypothesis, we will first examine glucose metabolism and cellular bioenergetics in normal and xCT-mutant muscle cells during growth and differentiation. We will then examine these cells’ oxidative stress and redox capacity throughout differentiation. Finally, we will use a special form of glucose (13C-isotope) to trace how muscle cells process and use glucose in different ways during their growth and differentiation. By better understanding the role of xCT in controlling SKM metabolism and redox status, we will uncover new opportunities for developing novel therapeutic strategies for diseases related to SKM.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
507031
Name
Karam Charbel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cystine/glutamate antiporter roles in skeletal muscle glucose metabolism throughout differentiation
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Glutathione; Metabolism; Metabolomics; Mitochondrial Energetics; Muscular Dystrophies; Reactive Oxygen Species; Redox Biology; Skeletal Muscle; Tracer Studies; Xct
Abstract
Skeletal muscles (SKM) have the remarkable ability to regenerate following injury; however, this healing process relies on a careful balance of reactive oxygen species. In fact, disturbances in this balance are often linked to diseases in muscles like muscular dystrophies. To maintain this delicate balance, muscle cells use antioxidants like glutathione (GSH), which is made up of amino acids, including cysteine. Cysteine is brought into cells through a transporter called xCT. Despite the documented importance of xCT, we don't fully understand its role in muscle health. In our previous work in mice with a mutant xCT gene, we found that differentiated xCT-mutant muscle cells had lower GSH levels compared to normal mice, and higher capacities to use glucose for ATP synthesis through glycolysis and mitochondrial oxidative phosphorylation. These previous findings suggest that changes in xCT activity lead to glucose-dependent metabolic alterations in SKM under oxidative stress. Hence, we hypothesize that modulation of xCT activity elicits differential changes in how muscle cells use glucose during different stages of proliferation and differentiation. To investigate this hypothesis, we will first examine glucose metabolism and cellular bioenergetics in normal and xCT-mutant muscle cells during growth and differentiation. We will then examine these cells’ oxidative stress and redox capacity throughout differentiation. Finally, we will use a special form of glucose (13C-isotope) to trace how muscle cells process and use glucose in different ways during their growth and differentiation. By better understanding the role of xCT in controlling SKM metabolism and redox status, we will uncover new opportunities for developing novel therapeutic strategies for diseases related to SKM.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Karam, Charbel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~